140 related articles for article (PubMed ID: 1293772)
41. Non-Hodgkin's lymphoma in Saskatchewan. A review of 10 years' experience.
Maksymiuk AW; Bratvold JS; Ezzat W; Tan LK; Skinnider LF
Cancer; 1994 Feb; 73(3):711-9. PubMed ID: 8299094
[TBL] [Abstract][Full Text] [Related]
42. Presenting features, natural history, and prognostic factors in localized non-Hodgkin's lymphomas: analysis of 117 cases from a single institution.
Esteve J; López-Guillermo A; Martínez-Francés A; Bosch F; Terol MJ; Campo E; Montserrat E; Rozman C
Eur J Haematol; 1995 Oct; 55(4):217-22. PubMed ID: 7589337
[TBL] [Abstract][Full Text] [Related]
43. Prognostic significance of serum beta-2 microglobulin in patients with non-Hodgkin lymphoma.
Wu L; Wang T; Gui W; Lin H; Xie K; Wang H; Gao T; Zhang X; Liu L; Han T; Tian Y; Hou L
Oncology; 2014; 87(1):40-7. PubMed ID: 24969158
[TBL] [Abstract][Full Text] [Related]
44. Prognostic factors in high and intermediate grade non-Hodgkin's lymphoma.
Cowan RA; Jones M; Harris M; Steward WP; Radford JA; Wagstaff J; Deakin DP; Crowther D
Br J Cancer; 1989 Feb; 59(2):276-82. PubMed ID: 2930692
[TBL] [Abstract][Full Text] [Related]
45. Prognostic factors for patients with diffuse large cell or immunoblastic non-Hodgkin's lymphomas: experience of the non-Hodgkin's Lymphoma Pathologic Classification Project.
Simon R; Durrleman S; Hoppe RT; Bonadonna G; Bloomfield CD; Rudders RA; Cheson BD; Berard CW
Med Pediatr Oncol; 1990; 18(2):89-96. PubMed ID: 2406556
[TBL] [Abstract][Full Text] [Related]
46. [Clinicopathological features and prognostic factors of 216 cases with primary gastrointestinal tract non-Hodgkin's lymphoma].
Yin WJ; Wu MJ; Yang HY; Zhu X; Sun WY
Zhonghua Xue Ye Xue Za Zhi; 2013 May; 34(5):377-82. PubMed ID: 23688745
[TBL] [Abstract][Full Text] [Related]
47. Mitotic activity in non-Hodgkin's lymphoma. Relation to the Kiel classification and to prognosis.
Akerman M; Brandt L; Johnson A; Olsson H
Br J Cancer; 1987 Feb; 55(2):219-23. PubMed ID: 3814492
[TBL] [Abstract][Full Text] [Related]
48. A new serologic index for low-grade non-Hodgkin's lymphoma based on initial CA125 and LDH serum levels.
Benboubker L; Valat C; Linassier C; Cartron G; Delain M; Bout M; Fetissof F; Lefranq T; Lamagnere JP; Colombat P
Ann Oncol; 2000 Nov; 11(11):1485-91. PubMed ID: 11142490
[TBL] [Abstract][Full Text] [Related]
49. Ocular adnexal lymphoma classified using the WHO classification: not only histology and stage, but also gender is a predictor of outcome.
Plaisier MB; Sie-Go DM; Berendschot TT; Petersen EJ; Mourits MP
Orbit; 2007 Jun; 26(2):83-8. PubMed ID: 17613853
[TBL] [Abstract][Full Text] [Related]
50. Prognostic factors in primary gastrointestinal non-Hodgkin's lymphoma. A multivariate analysis, report of 106 cases, and review of the literature.
Azab MB; Henry-Amar M; Rougier P; Bognel C; Theodore C; Carde P; Lasser P; Cosset JM; Caillou B; Droz JP
Cancer; 1989 Sep; 64(6):1208-17. PubMed ID: 2670184
[TBL] [Abstract][Full Text] [Related]
51. Comparison of S-phase fraction, working formulation, and Kiel classification in non-Hodgkin's lymphoma.
Joensuu H; Klemi PJ; Söderström KO; Jalkanen S
Cancer; 1991 Oct; 68(7):1564-71. PubMed ID: 1893358
[TBL] [Abstract][Full Text] [Related]
52. Survival in patients with oral and maxillofacial diffuse large B-cell lymphoma.
Guevara-Canales JO; Morales-Vadillo R; Cava-Vergiú CE; Leite FP; Miranda Chaves Netto HD; Soares FA; Chaves Md
Braz Oral Res; 2013; 27(4):349-55. PubMed ID: 23752483
[TBL] [Abstract][Full Text] [Related]
53. Non-Hodgkin's lymphomas: characteristics of long-term survivors following conservative treatment.
Straus DJ; Gaynor JJ; Leiberman PH; Filippa DA; Koziner B; Clarkson BD
Am J Med; 1987 Feb; 82(2):247-56. PubMed ID: 3812517
[TBL] [Abstract][Full Text] [Related]
54. Prognostic factors and survival in non-Hodgkin's lymphomas: the experience of the Istituto Oncologico Romagnolo (IOR).
Pasquini E; Nicolini M; Rosti G; Amadori M; Pileri S; Nanni O; Fattori PP; Marangolo M; Amadori D; Ravaioli A
Leuk Lymphoma; 1994 Aug; 14(5-6):475-82. PubMed ID: 7812208
[TBL] [Abstract][Full Text] [Related]
55. Heat production rate in blood lymphocytes as a prognostic factor in non-Hodgkin's lymphoma.
Monti M; Brandt L; Ikomi-Kumm J; Olsson H
Eur J Haematol; 1990 Nov; 45(5):250-4. PubMed ID: 2261950
[TBL] [Abstract][Full Text] [Related]
56. Non-Hodgkin's lymphoma: time trends for incidence and survival in Côte-d'Or, France.
Rolland-Portal I; Tazi MA; Milan C; Couillault C; Carli PM
Int J Epidemiol; 1997 Oct; 26(5):945-52. PubMed ID: 9363514
[TBL] [Abstract][Full Text] [Related]
57. Is the International Prognostic Index for aggressive lymphomas useful for low-grade lymphoma patients? Applicability to stage III-IV patients. The GOELAMS Group, France.
Foussard C; Desablens B; Sensebe L; François S; Milpied N; Deconinck E; Delwail V; Dugay J; Lamy T; Ghandour C; Le Mevel A; Maisonneuve H; Casassus P; Colombat P
Ann Oncol; 1997; 8 Suppl 1():49-52. PubMed ID: 9187429
[TBL] [Abstract][Full Text] [Related]
58. S-phase fraction by the labeling index as a predictive factor for progression and survival in low grade non-Hodgkin's lymphoma.
Witzig TE; Habermann TM; Kurtin PJ; Schroeder G; Stenson MJ; Greipp PR
Cancer; 1995 Sep; 76(6):1059-64. PubMed ID: 8625208
[TBL] [Abstract][Full Text] [Related]
59. Prognostic factors in head and neck non-Hodgkin's lymphoma with special reference to serum lactic dehydrogenase and serum copper.
Hisamitsu S; Shibuya H; Hoshina M; Horiuchi J
Acta Oncol; 1990; 29(7):879-83. PubMed ID: 2261202
[TBL] [Abstract][Full Text] [Related]
60. Prognostic factors in non-Hodgkin lymphomas.
Cecyn KZ; Oliveira JS; Alves AC; Silva MR; Kerbauy J
Sao Paulo Med J; 2000 Jan; 118(1):7-12. PubMed ID: 10685121
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
